arthur j higgins arthur j higginspresident and chief executive officer mr higgins joined depomed as president and chief executive officer and director in march  he brings over  years of pharmaceutical and healthcare industry experience most recently he served as a senior advisor to blackstone healthcare partners the dedicated healthcare team of the blackstone group where he focused on productbased healthcare acquisitions prior to that mr higgins served as chairman of the board of management of bayer healthcare ag from january  to may  and chairman of the bayer healthcare executive committee from july  to may  prior to joining bayer healthcare in  mr higgins served as chairman president and chief executive officer of enzon pharmaceuticals inc from  to  prior to joining enzon pharmaceuticals mr higgins spent  years with abbott laboratories including serving as president of the pharmaceutical products division from  to  he is a past member of the board of directors of the pharmaceutical research and manufacturers of america phrma of the council of the international federation of pharmaceutical manufacturers and associations ifpma and president of the european federation of pharmaceutical industries and associations efpia mr higgins serves on the boards of zimmer biomet a publicly held medical device company and ecolab a publicly held water hygiene and energy technologies and services company mr higgins received a bs in biochemistry from strathclyde university scotland about us management arthur j higgins sharon d larkin matthew m gosling august j moretti srinivas g rao thadd m vargas board of directors james p fogarty karen a dawes arthur j higgins louis j lavigne jr william t mckee gavin t molinelli robert g savage peter d staple james l tyree compliance contact us directions home about us products pipeline technology clinical trials investors careers sitemap contact us a growing specialty pharmaceutical company  depomed inc    all rights reserved terms of use privacy policy website design hane chow inc apldep rev  arthur j higgins  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in arthur j higgins board member at zimmer biomet holdings inc view full profile are you arthur j higgins claim your profile   sign up for equilar atlas and view arthur j higginss full profile with equilar atlas you can identify corporate executives in arthur j higginss network and community follow changes in arthur j higginss employment and moneyinmotion connect with arthur j higgins through your network of contacts arthur j higginss executive work history current board member ecolab inc board member zimmer biomet holdings inc past to view arthur j higginss complete executive work history sign up now age      arthur j higginss biography arthur j higgins has served as president and chief executive officer of the company since march  since  he has served as a senior advisor to blackstone healthcare partners the dedicated healthcare team of the blackstone group where he focused on productbased healthcare acquisitions prior to joining the blackstone group in  mr higgins served as chair of the board management of bayer healthcare ag a developer and manufacturer of human and animal health care products and chairman of the bayer healthcare executive committee prior to joining bayer healthcare in  mr higgins served as chairman president and chief exec  read more arthur j higgins has served as president and chief executive officer of the company since march  since  he has served as a senior advisor to blackstone healthcare partners the dedicated healthcare team of the blackstone group where he focused on productbased healthcare acquisitions prior to joining the blackstone group in  mr higgins served as chair of the board management of bayer healthcare ag a developer and manufacturer of human and animal health care products and chairman of the bayer healthcare executive committee prior to joining bayer healthcare in  mr higgins served as chairman president and chief executive officer of enzon pharmaceuticals from  to  prior to joining enzon mr higgins spent  years at abbott laboratories most recently as president of the pharmaceutical products division from  to  he is a past member of the board of directors of the pharmaceutical research manufacturers of america phrma of the council of the international federation of pharmaceutical manufacturers and association ifpma and president of the european federation of pharmaceutical industries and associations efpia the board considered mr higgins experience and expertise within the following areas relevant to the company and its business in concluding that he should serve on the board corporate management commercial strategy corporate strategy corporate leadership and board experience mr higgins is a director of ecolab inc and zimmer holdings inc mr higgins holds a bs in biochemistry from strathclyde university scotland source depomed inc on    sign up for equilar atlas and view arthur j higginss full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like arthur j higgins more specifically youll be able to identify corporate executives in arthur j higginss network and community follow changes in arthur j higginss employment and moneyinmotion connect with arthur j higgins through your network of conections view full profile   search for over  executive profiles bio example arthur j higgins arthur j higginss connections  sign up now to view arthur j higginss  connections » james j seifert executive vice president general counsel  secretary ecolab inc jerry w levin lead independent director ecolab inc christopher b begley chairman of the board adtalem global education inc joel w johnson board member meredith corporation robert l parkinson former chief executive officer president and chairman of the board baxter international inc james h white former vice president and chief operating officer libbey inc christophe beck executive vice president and president global water and process services ecolab inc james a miller former executive vice president and president global corporate initiatives ecolab inc james t crines former executive vice president finance and chief financial officer zimmer biomet holdings inc larry c glasscock board member sysco corporation popular profiles sign up now to view more executive profiles » john j kita evp and cfo a o smith elon r musk ceo and chairman tesla thomas j lynch executive chairman te connectivity ltd jan koum board member facebook inc robert d perlmutter senior evp and coo the macerich company × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   arthur higgins  european federation of pharmaceutical industries and associations  zoominfocom arthur j higgins joins endo board of directors arthur j higgins joins endo board of directors dec    et from endo health solutions malvern pa dec   prnewswire  endo health solutions nasdaq endp today announced that arthur j higgins has been appointed to its board of directors effective immediately  endo also announced that joseph c scodari  will retire as a director effective december   recognized for his strategic capabilities mr higgins has over  years of domestic and international pharmaceutical industry experience he is currently a senior advisor to blackstone healthcare partners the dedicated healthcare team of the blackstone group where he focuses on productbased healthcare acquisitions  prior to joining blackstone he served as chairman of the board of management of bayer healthcare ag and chairman  ceo of enzon pharmaceuticals     commenting on todays announcement roger kimmel chairman of endos board said we are pleased to welcome art higgins to the endo board  given the depth and breadth of his healthcare and pharmaceutical industry experience we are confident that his unique insight and international perspective will be valuable resources as endo continues its transformation into a more focused global specialty healthcare company mr higgins stated i believe that endo has a differentiated strategy and a management team that can execute this strategy well  endo is wellpositioned to continue to offer products that make a difference in the lives of patients while generating superior growth and returns for shareholders i am honored to join the board of a fastgrowing leader in the healthcare industry and look forward to contributing to endos momentum mr kimmel added on behalf of the board of directors i would like to extend our sincere appreciation to joe scodari for his valuable and tireless contributions to the board over many years and wish him the best in his future endeavors mr scodari stated it has been a pleasure to serve on the endo board of directors for the past five years  i am confident that endo has the right leadership and a clear vision in place for its next phase of growth and i wish the company continued success biography of arthur j higgins art higgins  has over  years of experience in the pharmaceutical industry  he is currently a senior advisor to blackstone healthcare partners the dedicated healthcare team of the blackstone group where he focuses on productbased healthcare acquisitions prior to that mr higgins served as chairman of the board of management of bayer healthcare ag a developer and manufacturer of human and animal health products and chairman of the bayer healthcare executive committee prior to joining bayer healthcare in  mr higgins served as chairman president and chief executive officer of enzon pharmaceuticals inc from  to  prior to joining enzon pharmaceuticals mr higgins spent  years with abbott laboratories including serving as president of the pharmaceutical products division from  to  mr higgins currently serves on the boards of ecolab inc resverlogix corp and zimmer holdings inc he is a past member of the board of directors of the pharmaceutical research and manufacturers of america phrma of the council of the international federation of pharmaceutical manufacturers and associations ifpma and president of the european federation of pharmaceutical industries and associations efpia mr higgins has a bs in biochemistry from strathclyde university in glasgow scotland  about endo endo health solutions inc endo is a usbased specialty healthcare company with four distinct business segments that are focused on branded and generic pharmaceuticals devices and services each providing quality products to our customers while improving the lives of patients through our operating companies – ams endo pharmaceuticals healthtronics and qualitest – endo is dedicated to finding solutions for the unmet needs of patients learn more at wwwendocom safe harbor statement this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of   statements including words such as believes expects anticipates intends estimates plan will may look forward intend guidance future or similar expressions are forwardlooking statements  because these statements reflect our current views expectations and beliefs concerning future events these forwardlooking statements involve risks and uncertainties investors should note that many factors as more fully described under the caption risk factors in our form k form q and form k filings with the securities and exchange commission and as otherwise enumerated herein or therein could affect our future financial results and could cause our actual results to differ materially from those expressed in forwardlooking statements contained in our annual report on form k the forwardlooking statements in this press release are qualified by these risk factors these are factors that individually or in the aggregate could cause our actual results to differ materially from expected and historical results we assume no obligation to publicly update any forwardlooking statements whether as a result of new information future developments or otherwise source endo health solutions related links httpwwwendocom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more dec    et preview endo health solutions announces proposed private offering of senior notes nov    et preview endo health solutions announces consent solicitation to amend senior notes my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search   arthur higgins joins blackstone’s healthcare team dbcacebab media stay up to date with the latest blackstone news overview press releases market commentary videos blog press releases   receive press releases by email jun   arthur higgins joins blackstone’s healthcare team new york june   – the blackstone group nyse bx today announced that arthur j higgins former chairman of the board of management of bayer healthcare ag has joined the firm’s dedicated healthcare group blackstone healthcare partners at blackstone mr higgins will join health care veterans lodewijk de vink and doug rogers in providing industry knowledge and expertise to private equity transactions blackstone healthcare partners is an integral part of the firm’s global effort in sourcing analyzing and overseeing investments in pharmaceuticals and medical products blackstone healthcare group’s investments include nycomed gerresheimer stiefel laboratories and catalent tony james president and coo of blackstone said “with the addition of arthur higgins we have further strengthened blackstone healthcare partners they offer a unique value to companies wishing to access focused industry expertise of this group of leading healthcare stars along with capital to fund growth” mr higgins had been chairman of the bayer healthcare executive committee since july   and chairman of the board of management of bayer healthcare ag since january   during his tenure at bayer mr higgins led the restructuring and strengthening of bayer healthcare including the acquisition and integration of schering ag and the overthecounter medicines business of roche mr higgins started his career in  in britain with bristolmyers he subsequently worked for sandoz  to  and fisons  to  before moving to abbott laboratories in the usa  to  where he held positions of increasing responsibility in the international and domestic divisions including a twoyear posting in germany he was appointed president of the pharmaceutical products division in chicago in  in this position he was in charge of abbott’s pharmaceuticals business in the us with responsibility for global pharmaceutical research and development in  mr higgins was appointed chairman and ceo of enzon pharmaceuticals headquartered in bridgewater nj in this function he also served as chairman of the biotech council of new jersey and on the board of the us national pharmaceutical council mr higgins has been a member of the executive committee of the pharmaceutical research and manufacturers of america phrma a member of the executive council of the international federation of pharmaceutical manufacturers and associations ifpma and president of the european federation of pharmaceutical industry association efpia  he is a member of the board of directors of zimmer inc eco labs and resverlogix corp about blackstone blackstone is one of the world’s leading investment and advisory firms we seek to create positive economic impact and longterm value for our investors the companies we invest in the companies we advise and the broader global economy we do this through the commitment of our extraordinary people and flexible capital our alternative asset management businesses include the management of private equity funds real estate funds funds of hedge funds creditoriented funds collateralized loan obligation vehicles clos and closedend mutual funds the blackstone group also provides various financial advisory services including financial and strategic advisory restructuring and reorganization advisory and fund placement services further information is available at wwwblackstonecom contact public affairs the blackstone group new york    quick links explore blackstone get in touch back to top   the blackstone group lp  english   chinese transparency  disclosure  legal  privacy  cookie notice  japan disclaimer プライバシー・ポリシー   にづく ブラックストーン・グループ・ジャパン （）　一般社団法人二種金融商品取引業協会 ×stay uptodateemail alertsto receive email notifications when press releases or byron wiens market commentaries are posted sign up for email alerts here email address required first name required last name required company name job title byron wien market commentary blackstone press releases   submit cookie information and consent requestblackstone cookie policythis website uses cookies including thirdparty cookies which allow blackstone to obtain information about your visit to the website please click on the link learn more below if you would like more information about the cookies used on this website and how to select certain cookies you will also be able to refuse the installation of certain cookies by continuing to use this website clicking on a picture or link under this banner you consent to the use of cookies learn more continue × contact usgeneralfor officespecific contact information please visit our offices page switchboard   email alerts  investor relationsto receive email notifications when press releases or byron wien’s market commentaries are posted sign up for email alerts here for investor relations contact information or to receive email notifications for sec filings events end of day stock quotes and financial reports please visit our investor relations page investor relations contact informationus  international  blackstoneinvestorrelationsblackstonecom media contactsfor media inquiries or recent press releases please click here arthur j higgins of ecolab inc executive profile   ecolab inc  ecl overviewexecutive compensationinsider activitykey executivesboard of directorscommittees key executives  arthur j higgins arthur j higgins independent director profile connections biography consultant blackstone healthcare partners of the blackstone group director of ecolab since  vice chair of the governance committee and member of the compensation committee mr higgins joined the blackstone group in  prior to that mr higgins served as chairman of the board of management of bayer healthcare ag a developer and manufacturer of human and animal health products and chairman of the bayer healthcare executive committee prior to joining bayer healthcare in  mr higgins served as chairman president and chief executive officer of enzon pharmaceuticals inc from  to  prior to joining enzon pharmaceuticals mr higgins spent  years with abbott laboratories most recently as president of the pharmaceutical products division from  to  he is a past member of the board of directors of the pharmaceutical research and manufacturers of america phrma of the council of the international federation of pharmaceutical manufacturers and associations ifpma and president of the european federation of pharmaceutical industries and associations efpia board membership company name board member since board committees zimmer biomet holdings inc  auditboardcompensation and management developmentcorporate governanceresearch innovation and technology depomed inc  board ecolab inc  auditboardcompensationgovernance arthur j higgins is connected to  board memberssee list of all board connections   higgins arthur j top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active higgins arthur j • warsaw in how do i update this listing higgins arthur j is based out of warsaw summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from higgins arthur j enter your email address below and choose submit your email cancel contact info higgins arthur j co zimmer inc warsaw in     sec sic codebiological products no disgnostic substances recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free form  depomed inc for mar  filed by higgins arthur j research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  depomed inc for mar  filed by higgins arthur j by k wizard—  pm et  httparchivefastedgarcomarzzczazkgzzenfzzrzh filed on april   more depo news depomed announces prepayment of  million of secured debt facility globenewswire   am et  depomed announces cooperation agreement with starboard value lp including ceo and board changes globenewswire   pm et  depomed to present at healthcare conferences in march globenewswire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top sbgi log in for events holx caty gmed aehr pbf log in for events ryi tier etm sons find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  pm et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  depo stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventsdepo depomed inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all briefdepomed says former ceo james a schoenecks  total compensation was  million reuters –  pm et  depomed inc depo  former ceo james a schoenecks  total compensation was  million versus  million in  source text for eikon further company coverage briefdepomed announces intent to effect a debt refinancing reuters –  am et  depomed inc depo  depomed depo announces intent to effect a debt refinancing  seeking to refinance its existing  million principal amount of privately placed secured senior notes  existing notes are due in  and have a coupon of  over threemonth libor  currently expects net sales to be in range of approximately  million to  million for quarter ended june   depomed announces intent to effect a debt refinancing globenewswire –  am et  depomed inc depo today announced that it is seeking to refinance its existing  million principal amount of privately placed secured senior notes the consummation and actual terms of the proposed refinancing are subject to a number of factors including market conditions negotiation and execution of definitive agreements and satisfaction of customary closing conditions breakfast technical briefing on drug makers stocks  synergy pharma novo nordisk pernix therapeutics and depomed pr newswire –  am et  new york july   if you want a stock review on sgyp nvo ptx or depo then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister synergy pharma  new york headquartered synergy pharmaceuticals incs sgyp shares declined  closing mondays trading session at  the stock recorded a trading volume  briefdepomed chief medical officer srinivas rao resigns reuters –  pm et  depomed inc depo  depomed inc depo  on june  co entered agreement with srinivas g rao cos chief medical officer pursuant to which dr rao to resign as officer of co source text for eikon further company coverage how these drug makers stocks are faring  depomed pernix therapeutics united therapeutics and orexigen therapeutics pr newswire –  am et  new york may   on tuesday may   the nasdaq composite the dow jones industrial average and the sp  edged lower at the closing bell httpstockcallerscomregistration briefdepomed announces corporate governance updates reuters –  am et  depomed inc depo  depomed depo  revised each of charters of audit committee compensation committee nominating and corporate governance committee  depomed inc depo  revised its corporate governance guidelines to among other things formally require chairman of board to be an independent director depomed announces corporate governance updates globenewswire –  am et  depomed inc depo today announced that following a comprehensive review of the companys corporate governance practices the board of directors has taken a number of actions designed to ensure that the companys policies are further aligned with shareholder interests and corporate governance best practices depomed to present at the ubs global healthcare conference globenewswire –  pm et  depomed inc depo today announced that members of senior management will participate in a fireside chat at the  ubs global healthcare conference scheduled for  am et on tuesday may   in new york new york stock winners and losers  nvidia rockets and yelp tumbles marketwatch –  am et  earnings season is creating volatility in the us equity market earnings season brings out volatility in stock prices which can be lucrative if youre targeting the right companies shares of yelp inc yelp were down  on wednesday after it lowered its sales outlook because of an outflow of local advertising customers briefdepomed reports q adjusted nongaap earnings shr reuters –  pm et  depomed depo  depomed depo announces first quarter  financial results and strategic initiatives aimed at driving sustainable longterm growth and shareholder value  q adjusted nongaap earnings per share   q gaap loss per share   q revenue  million versus ibes view  million  sees fy  revenue  million to  million depomed shares down  after earnings miss marketwatch –  pm et  shares of depomed inc depo fell more than  late tuesday after the drug company reported firstquarter adjusted pershare earnings and revenue below expectations depomed depo said it lost  million or  cents a share in the first quarter compared with a loss of  million or  cents a share in the yearago quarter adjusted for onetime items depomed depo earned  million or  cents a share in the quarter compared with  million or  cents a share a year ago depomed announces first quarter  financial results and strategic initiatives aimed at driving sustainable longterm growth and shareholder value globenewswire –  pm et   first quarter gaap revenues of  million nongaap revenues of  million  company announces implementation of strategic initiatives to drive portfolio growth    nongaap revenue guidance of  to  million inclusive of an expected wholesaler inventory reduction  conference call scheduled for today at  pm edt dial in information below  newark calif may     depomed to report first quarter  financial results on tuesday may   globenewswire –  pm et  depomed inc depo today announced that it will release first quarter fiscal year  financial results on tuesday may   after the close of markets participants can access the call by dialing  or  referencing conference id  about depomed depomed announces appointment of sharon d larkin as senior vice president human resources and administration globenewswire –  am et  depomed inc depo today announced that sharon d larkin joined depomed as senior vice president human resources and administration ms larkin brings over  years of global human resources leadership to this role research reports initiation on drug makers stocks  depomed pernix therapeutics orexigen therapeutics and united therapeutics pr newswire –  am et  new york april   todays research on stockcallerscom is focused on the drug manufacturers space which is engaged in the development of prescription and overthecounter products that are used to prevent or treat illnesses in humans or animals httpstockcallerscomregistration depomed announces prepayment of  million of secured debt facility globenewswire –  am et   company intends to refinance the remainder of secured debt in    continues commitment to delevering the company  depomed inc depo today announced that in accordance with its stated plans and the terms of the secured debt facility with deerfield and pharmakon advisors lp the company prepaid  million of principal amount of its  million secured indebtedness depomed announces cooperation agreement with starboard value lp including ceo and board changes globenewswire –  pm et  pharmaceutical veteran arthur j higgins joins as president ceo and director three new directors named to board james fogarty named new chairman of the board q  net sales estimated to be  million newark calif march    depomed inc depo today announced that arthur j higgins has joined the company as president and chief executive officer and member of the board of d depomed to present at healthcare conferences in march globenewswire –  am et  depomed inc depo today announced that senior management will present at the following healthcare conferences during the month of march th annual roth conference date monday march   time  pm pdt location dana point california oppenheimer th annual healthcare conference date tuesday march   time  am edt location new york new york depomed reports fourth quarter and full year  financial results globenewswire –  pm et   record annual revenue of  million in    record quarterly revenue of  million in fourth quarter –  conference call scheduled for today at  pm est dialin information below  depomed inc depo today reported financial results and highlighted operational achievements for the quarter and twelve months ended december   and provided  guidance page page   next  todays and upcoming events aug  depo to announce q earnings after market unconfirmed aug  shareholders meeting past events last  days no events in the past  days data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe